第五章 鼻咽癌2008分期JRO版.pdfVIP

J Radiat Oncol DOI 10.1007/s13566-013-0088-5 REVIEW Report on revision of the Chinese 1992 staging system for nasopharyngeal carcinoma Chinese Committee for Staging of Nasopharyngeal Carcinoma Received: 25 November 2012 /Accepted: 2 January 2013 L # Springer-Verlag Berlin Heidelberg 2013 A Abstract With the advances of diagnostic imaging and Introduction radiation therapy technology, the limitations of the Chinese 1992 staging system for nasopharyngeal carcinoma (NPC) Cancer staging plays one of the most important roles in the V become obvious, and the revision of this system was clearly management of cancer. It forms the basis for understanding needed. On December 16, 2008, the Chinese Committee for the changes in cancer incidence in a population, extent of Staging of Nasopharyngeal Carcinoma (CCSNPC) was inau- disease at initial presentation, and the overall impact of O gurated in Guangzhou, China, with the purpose of establish- improvements in cancer treatment. Staging also forms the ing a platform for the study of the Chinese staging system and base for defining groups for inclusion in clinical trials. More ensuring the continuity of the work of NPC staging research. importantly, staging provides patients and their physicians Data from published studies on staging of NPC were collected with the critical benchmark for defining prognosis, the like- R and reviewed. After extensive evaluation and discussion, the lihood of disease control, and the basis for determining the Chinese 2008 staging system for NPC